Bempedoic acid/Ezetimibe Prescribing at SAFFRON HEALTH PARTNERSHIP
Lipid-regulating drugs | Cardiovascular System
Items (12m)
148
Total Quantity
4,144
NHS Cost
£7.8K
vs National Avg
+142.4%
SAFFRON HEALTH PARTNERSHIP prescribed 148 items of Bempedoic acid/Ezetimibe over the last 12 months at a cost of £7,773 to the NHS. This is 142.4% above the national average prescribing rate. Bempedoic acid/Ezetimibe is classified under Lipid-regulating drugs in the BNF.
Monthly Prescribing Trend
Jul 2026
9
Jul 2026
6
Jul 2026
7
Jul 2026
6
Jul 2026
11
Jul 2026
11
Jul 2026
10
Jul 2026
16
Jul 2026
17
Jul 2026
12
Jul 2026
20
Jul 2026
23
Prescribing Details
| Total Items | 148 |
|---|---|
| Total Quantity | 4,144 |
| Total NHS Cost | £7,773 |
| Presentations | 1 different forms |
| vs National Average | +142.4% |
Bempedoic acid/Ezetimibe Prescribing Comparison
| This practice | 148 items |
|---|---|
| National average per practice | 61 items |
| Difference | +142.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.